About the Company -Monogram Orthopaedics is a company focused on disrupting the orthopedics industry by offering innovative solutions to an old process, a process that allows for “good enough” products and processes in the orthopedic implant market. Innovating in this market is costly, leading to a monopoly in the market by four companies: Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. Monogram Orthopaedics, a California based biotech company, is challenging these companies by pushing for a desperately needed update to the implant market. They’re doing this in two ways, the first is by producing their parts through 3D printing which allows the parts to be customizable to each patient’s unique specifications rather than standard, mass produced implants. The second is by using machine learning and robotics to implant different body part replacements, allowing for a significantly better outcome compared to the current process that utilizes less capable robots. Here is a video of one of the Monogram robots in action with its advanced tracking abilities:
According to internal studies conducted by the company, their process shows a better fit, increased accuracy, and more bone contact. Below is another video where the founders and leading scientists working on the project explain even further the potential this technology has to offer. In this video, they explain how current implants for a knee are flat and a one size fits all, while Monogram’s process allows for implants that follow the natural curvature and shape of each individual’s knee.
Why Invest? – According to Seedinvest, over 700,000 knee replacement surgeries are performed each year in the United States alone, each one using the same, standard implants that have been on the market for years. Now that Monogram has developed the technology for customizable implants, why should we sit back and allow slow innovation by large companies who control the market? Monogram would be an excellent company to invest in because of their potential to break out into a high demand market. Once this technology becomes available, no one will want to stick with the one size fits all method from the past. When it comes to surgical procedures, many are anxious to undergo an operation, knowing they will be fitted with implants specific to their body would help ease their minds.
I personally believe that one of the most important questions to ask yourself when deciding whether or not to invest is, “will this product better people’s lives?” You can look at nearly any product that substantially increases the quality or ease of a person’s life and that product is a success. By providing custom fit orthopedic implants and higher quality procedures, Monogram is improving both the ease and quality with which this procedure is performed, bettering lives at the same time. Monogram is not taking investments just yet, however you can find more specific details about them as well as reserve your spot for when they do begin taking investments here.
Take Note– This company was founded in 2015, so, while still promising, it is relatively new, and I should note that most startups fail. However I personally believe this company has the capability to disrupt their targeted industry and provide a great opportunity to investors. At a current market evaluation of just over 21 million dollars, this biotech company is full of potential to go far.
If you would like to hear about more innovative startups feel free to click the follow button below!
Disclaimer: I am not a licensed financial advisor, this opinion is just my own. This should not be considered financial advice, if you want professional licensed advice, consult a financial advisor.
Innovative Lifestyle 